Development of the European Commission Initiative on Breast Cancer Guidelines
Authors: Joseph Watine
Journal: Annals of Internal Medicine (2020)

Letters7 January 2020Development of the European Commission Initiative on Breast Cancer GuidelinesJoseph Watine, PharmDJoseph Watine, PharmDHôpital de La Chartreuse, Villefranche-de-Rouergue, France (J.W.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0620 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I read Schünemann and colleagues' article (1) with interest. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) working group has invented concepts and defined methods to develop practice guidelines. The GRADE system tends to become the gold standard worldwide, and with good reason. For example, this framework has been endorsed by the European Commission to develop their breast cancer guidelines (1). These guidelines state, “for asymptomatic women aged 50 to 69 with an average risk of breast cancer, mammography screening is recommended in the context of an organised screening programme (strong recommendation, moderate certainty in the ...References1. Schünemann HJ, Lerda D, Dimitrova N, et al; European Commission Initiative on Breast Cancer Contributor Group.. Methods for development of the European Commission Initiative on Breast Cancer guidelines: recommendations in the era of guideline transparency. Ann Intern Med. 2019;171:273-80. [PMID: 31330534]. doi:10.7326/M18-3445 LinkGoogle Scholar2. European Commission. Recommendations from the European Breast Cancer guidelines. Updated 2019. Accessed at https://ecibc.jrc.ec.europa.eu/recommendations on 31 July 2019. Google Scholar Author, Article, and Disclosure InformationAffiliations: Hôpital de La Chartreuse, Villefranche-de-Rouergue, France (J.W.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0620. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoMethods for Development of the European Commission Initiative on Breast Cancer Guidelines Holger J. Schünemann , Donata Lerda , Nadya Dimitrova , Pablo Alonso-Coello , Axel Gräwingholt , Cecily Quinn , Markus Follmann , Robert Mansel , Francesco Sardanelli , Paolo Giorgi Rossi , Annette Lebeau , Lennarth Nyström , Mireille Broeders , Lydia Ioannidou-Mouzaka , Stephen W. Duffy , Bettina Borisch , Patricia Fitzpatrick , Solveig Hofvind , Xavier Castells , Livia Giordano , Sue Warman , Zuleika Saz-Parkinson , and Development of the European Commission Initiative on Breast Cancer Guidelines Holger J. Schünemann , Pablo Alonso-Coello , Axel Gräwingholt , Cecily Quinn , Markus Follmann , Miranda Langendam , and Zuleika Saz-Parkinson Metrics Cited byTechnology and Surveillance in Times of Crisis, and Beyond: Lessons from Mobile Tracking Technology During the Covid-19 Outbreak 7 January 2020Volume 172, Issue 1Page: 72KeywordsBreast cancerCancer screeningConflicts of interestDisclosureGrading of Recommendations Assessment Development and EvaluationMammography ePublished: 7 January 2020 Issue Published: 7 January 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...